SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-023555
Filing Date
2022-06-17
Accepted
2022-06-17 16:05:54
Documents
12
Period of Report
2022-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cccc-8k_20220615.htm   iXBRL 8-K 35276
  Complete submission text file 0001564590-22-023555.txt   163186

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cccc-20220615.xsd EX-101.SCH 5597
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cccc-20220615_lab.xml EX-101.LAB 19331
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cccc-20220615_pre.xml EX-101.PRE 11494
6 EXTRACTED XBRL INSTANCE DOCUMENT cccc-8k_20220615_htm.xml XML 3546
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 221023780
SIC: 2836 Biological Products, (No Diagnostic Substances)